BioSpace News Archive

Genetown

Trinity Partners Reveals Findings on FDA-Approved Novel Drug Performance

Trinity Partners announced the findings of its second annual Trinity Drug Index which assessed all novel drugs approved by the FDA in 2014.

November 14, 2017

·

2 min read

Policy

Scilex Pharma, Sorrento’s Subsidiary, Files MAA in the European Union for ZTlido

Sorrento announced today that Scilex Pharma filed the European MAA for its lead product candidate, ZTlido through a hybrid regulatory pathway with the MHRA in the UK.

November 14, 2017

·

4 min read

Business

Bernoulli Health Collaborates With GE Healthcare to Enable Interoperability

Bernoulli Health announced today collaboration with GE Healthcare on the new CARESCAPE Connect data aggregation solution.

November 14, 2017

·

2 min read

Business

Ymir Genomics and the OHSU Knight Cancer Institute Announce Collaboration

The collaboration will exploit Ymir’s proprietary urinary extracellular vesicle technology and the expertise of the Knight Cancer Institute supported OHSU Proteomics Shared Resource.

November 14, 2017

·

3 min read

Medigate Announces $5.35M Seed Round to Protect Connected Medical Devices from Pandemic Cyberattacks Threatening Patient Safety and Privacy

The Medigate solution is a dedicated platform for securing networked medical devices that are connected to electronic medical records, device servers, other enterprise systems and the internet.

November 14, 2017

·

8 min read

Counsyl Celebrates Anniversary With $80M F

Genetown

Cambridge’s ImmusanT Nabs $40M

The cash will fund a randomized Phase II clinical trial of escalating doses of Nexvax2 in celiac patients who possess the human leukocyte antigen-DQ2.5 (HLA-DQ2.5) immune recognition gene.

November 14, 2017

·

5 min read

Pharm Country

Purdue Pharma L.P. Announces Strategic Investment in Oncology R&D

Purdue Pharma, L.P. today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet medical need.

November 14, 2017

·

4 min read

BioMidwest

Baxter Declares Quarterly Dividend

The dividend is payable on January 2, 2018, to stockholders of record as of December 1, 2017. The indicated annual dividend rate is $0.64 per share.

November 14, 2017

·

1 min read

BioMidwest

Riverain Technologies Release: ClearRead CT Adoption Continues to Accelerate

Riverain’s ClearRead CT install base has expanded in the U.S. as leading institutions see the value in its efficient and effective detection of lung nodules across all chest CTs, including lung cancer screening exams.

November 14, 2017

·

3 min read

Eyetronic Therapy: New Study Proves Long-Term Effect

A recent study led by Prof. Dr. Carl Erb[*] shows that the treatment with the Eyetronic system resulted in a stop of the progression of glaucoma in approximately 75% of patients one year after the therapy.

November 14, 2017

·

3 min read